Table 3.

Comparison between RCC and non-RCC malignant tumors

	RCC	non-RCC	p value
Total no. of patients	155	14
Age ± SD (years)	36.9 ± 7.1	27.14 ± 9.3	0.00001
No. of male patients (%)	112(72.2)	3(21.4)	0.0001
No. of female patients (%)	43(27.7)	11(78.6)	0.0001
No. of patients dead (%)	9(5.8)	4(28.6)	0.0006
Progression-free survival at 72 months in % (SE) for n = 131	72.0 (6.4)	58.3 (14.2)	0.03
Overall survival at 72 months in % (SE) for n = 131	84.2 (5.6)	63.6 (14.5)	0.02